Continuing risk of bluetongue
The pharmaceutical industry rose magnificently to the challenge posed by the incursion of bluetongue virus serotype 8 (BTV-8), and has since adapted its response to deal with the increasing threat of BTV-1, by producing killed vaccines that have provided the only feasible control strategy to reduce...
Gespeichert in:
Veröffentlicht in: | Veterinary record 2010-05, Vol.166 (18), p.570-570 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!